ADAGE CAPITAL MANAGEMENT, L.P.


Firm Description Adage Capital Management, L.P. (“ACM”) was formed on July 1, 2001. Bob Atchinson and Phill Gross are the managing partners and principal owners of the firm. Bob and Phill have worked together since 1985. ACM manages one fund, Adage Capital Partners, L.P. (“ACP”) and does not manage any separate accounts. Principal Owners Bob Atchinson and Phill Gross are the principal owners of ACM. Types of Advisory Services ACM manages ACP primarily through industry‐specific portfolios that are managed by analyst/portfolio manager teams or individuals. ACM’s analysts focus on adding value by stock selection based on intra‐industry fundamental analysis. In addition to taking long positions, ACM uses leverage, sells securities short, and invests in derivatives, U.S. and non‐U.S. equities and private securities. In addition, ACM may from time to time, as it determines in its discretion, utilize analysts focusing on additional methodologies for identifying investments for ACP, including risk arbitrage and other event driven opportunities. All limited partner investors in ACP share in gains and losses in proportion to their investment in ACP. Tailored Relationships Limited partners of ACP do not have the ability to individually tailor their investment or impose unique investment restrictions. Wrap Fee Programs ACM does not participate in wrap fee programs. Assets Under Discretionary and Non-Discretionary Management As of December 31, 2019, ACM has net assets under discretionary management of $31,367,100,000 (rounded to the nearest $100,000) and no assets under non‐discretionary management. Firm Brochure –Part 2A of Form ADV 6 March 9, 2020 please register to get more info

Open Brochure from SEC website
Assets
Pooled Investment Vehicles $45,471,401,992
Discretionary $45,471,401,992
Non-Discretionary $
Registered Web Sites

Related news

Sylebra supports Aeva and InterPrivate merger

Sylebra Capital has committed to invest $200 million to back the merger of Aeva Inc and InterPrivate Acquisition Corp.

Lidar startup Aeva raises another $200M ahead of its debut as a public company

Aeva, the lidar company started by two former Apple engineers, has raised an additional $200 million in private investment from Hong Kong hedge fund Sylebra Capital ahead of its debut as a publicly traded company.

Aeva, Inc. and InterPrivate Acquisition Corp. Announce $200 Million Investment from Sylebra Capital in Support of Business Combination

Aeva is backed by Adage Capital, Porsche SE ... from pre-eminent endowments and foundations to major pension funds. Forward-Looking Statements This press release contains certain forward-looking ...

Aeva, Inc. and InterPrivate Acquisition Corp. Announce $200 Million Investment from Sylebra Capital in Support of Business Combination

Aeva is backed by Adage Capital, Porsche SE ... from pre-eminent endowments and foundations to major pension funds. This press release contains certain forward-looking statements within the ...

Aeva, Inc. and InterPrivate Acquisition Corp. Announce $200 Million Investment from Sylebra Capital in Support of Business Combination

Aeva is backed by Adage Capital, Porsche SE ... from pre-eminent endowments and foundations to major pension funds. Forward-Looking Statements This press release contains certain forward-looking ...

Novus Therapeutics Announces Name Change to Eledon Pharmaceuticals; Provides Corporate Update and Outlook

Eledon is well financed to complete up to four Phase 2 clinical trials of lead candidate AT-1501, a potential best in class anti-CD40L monoclonal antibody IRVINE, Calif., Jan. 04, 2021 (GLOBE ...

Zosano Pharma Corp.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Gates Industrial Corp. PLC

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Royalty Pharma plc (NASDAQ:RPRX) Receives Average Rating of “Hold” from Analysts

Shares of Royalty Pharma plc (NASDAQ:RPRX) have been given an average recommendation of “Hold” by the ten analysts that are presently covering the firm, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a hold rating and four have issued a buy rating on the company.

34 Stocks Moving in Tuesday's Pre-Market Session

© 2021 Insider Inc. and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service and ...
Loading...
No recent news were found.